These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 5381795)
1. [Cytological and histochemical study of the epithelium in Trichomonas colpitis]. Brezhneva EIa Akush Ginekol (Mosk); 1969 Aug; 45(8):13-6. PubMed ID: 5381795 [No Abstract] [Full Text] [Related]
2. [Morphologic and histochemical changes in the mucosa of the urogenital tract in gonorrhea, trichomonas and candidiasis]. Bilik VG; Khaidarly IN Vestn Dermatol Venerol; 1971 May; 45(5):50-3. PubMed ID: 5122560 [No Abstract] [Full Text] [Related]
3. [The effect of metronidazole on the inflammatory changes in trichomonas vaginitis]. Mleziva J; Bouda J; Linhartová A Zentralbl Gynakol; 1968 Mar; 90(12):425-31. PubMed ID: 5710028 [No Abstract] [Full Text] [Related]
5. [Effects of hormonal changes in the vaginal environment in the treatment of vaginitis especially due to Trichomonas]. Lirosi G; Guarascio A Minerva Ginecol; 1972 Jan; 24(1):23-7. PubMed ID: 4671752 [No Abstract] [Full Text] [Related]
7. [Biocenosis of the vagina following treatment of trichomonas vaginitis with metronidazole]. Kuczyńska K Wiad Parazytol; 1977; 23(5):631-5. PubMed ID: 607578 [No Abstract] [Full Text] [Related]
9. [Mastocyte count in the vaginal wall in trichomonal colpitis]. Karag'ozov I; Popkhristova E Akush Ginekol (Sofiia); 1978; 17(1):41-3. PubMed ID: 637249 [No Abstract] [Full Text] [Related]
10. [Changes in vaginal epithelium in women with prolonged pregnancy and trichomonas vaginitis]. Tomasik K Ginekol Pol; 1977 Mar; 48(3):277-80. PubMed ID: 858523 [No Abstract] [Full Text] [Related]
11. [The role of urogenital trichomonas in the genesis of changes in the portio epithelium]. Tóth B; Simon J Zentralbl Gynakol; 1969 Apr; 91(17):547-51. PubMed ID: 5373787 [No Abstract] [Full Text] [Related]
12. The effect of metronidazole therapy on cervical histology in trichomoniasis. Gray B; Harper WF; Still RM J Obstet Gynaecol Br Commonw; 1967 Feb; 74(1):98-103. PubMed ID: 6018103 [No Abstract] [Full Text] [Related]
13. [Plasma and vaginal secretion concentrations following oral ornidazole in patients suffering from acute trichomonas colpitis]. Crevoisier CA; Eckert M; Haldemann R; Heizmann P; Richle R Gynakol Rundsch; 1980; 20(3):171-5. PubMed ID: 7192681 [No Abstract] [Full Text] [Related]
14. Vaginal PO2 in healthy women and in women infected with Trichomonas vaginalis: potential implications for metronidazole therapy. Rashad AL; Toffler WL; Wolf N; Thornburg K; Kirk EP; Ellis G; Whitehead WE Am J Obstet Gynecol; 1992 Feb; 166(2):620-4. PubMed ID: 1536244 [TBL] [Abstract][Full Text] [Related]
16. [Fluorescence diagnosis of Trichomonas colpitis and its frequency]. Stojanov S; Rost D Zentralbl Gynakol; 1983; 105(18):1194-6. PubMed ID: 6637249 [TBL] [Abstract][Full Text] [Related]
17. Clinical Effect of Metronidazole Vaginal Effervescent Tablet Combined with Flavescentis Sophora Suppository in the Treatment of Trichomonas Vaginitis. Shi L; Yang D; Wang X Contrast Media Mol Imaging; 2022; 2022():1250755. PubMed ID: 36017023 [TBL] [Abstract][Full Text] [Related]
18. [MK-915, a newreparation for the oral treatment of trichomonas colpitis]. Liechti R Schweiz Med Wochenschr; 1970 Dec; 100(49):2117-20. PubMed ID: 4924562 [No Abstract] [Full Text] [Related]